Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Unknown 1Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 10Kidney Neoplasms 9Neuroblastoma 4Melanoma 4Lung Neoplasms 2Leukemia 2Breast Neoplasms 2Uveal Melanoma 1Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Intestinal Neoplasms 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1

Interventions

Cisplatin 32Paclitaxel 29Radiotherapy 21Fluorouracil 20Radiation 12camrelizumab 11Oxaliplatin 11Docetaxel 11Carboplatin 10Capecitabine 9Esophagectomy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Leucovorin 6Endoscopic Mucosal Resection 6Drug Therapy 6apatinib 5Neoadjuvant Therapy 5Chemoradiotherapy 5nedaplatin 4S 1 (combination) 4Preoperative Exercise 4Irinotecan 4Endoscopy 4Cetuximab 4Albumin-Bound Paclitaxel 4pembrolizumab 3TP protocol 3Radiotherapy, Adjuvant 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Esophageal Neoplasms × aldesleukin × Clear all
NCT02662348 2016-01-25

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

The First Affiliated Hospital with Nanjing Medical University

Phase 1 Unknown
6 enrolled
Gastrointestinal

Esophageal Neoplasms, Gallbladder Neoplasms, Intestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡